Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

Kera, who is in her 40s but is often mistaken for a woman in her 20s, has shared her secret to maintaining a youthful ...

ATTR-CM is a disease in which harmful proteins build up in the heart, making it harder to pump blood, according to the ...

FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

The U.S. Food and Drug Administration (FDA) has announced a series of critical updates this week, reflecting its ongoing ...

Novartis NVS announced that the FDA has approved Fabhalta (iptacopan) for a third indication. The regulatory body approved the drug for the treatment of adults with C3 glomerulopathy (C3G) to reduce ...

The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...

More than 150,000 Americans could get diagnosed with colorectal cancer this year, but lifestyle changes can lower your risk, ...

Capricor Therapeutics’ investigational therapy deramiocel (CAP-1002) is being considered for approval in the U.S.

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...